Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
Abstract Aims Identification of patients with type 2 diabetes (T2D) at increased risk of incident heart failure (HF) beyond traditional risk factors such as prior myocardial infarction (MI) might allow selection of patients who would benefit from preventative treatment. Microvascular disease (MiVD)...
Main Authors: | Ify R. Mordi, Aaron Tee, Colin N. Palmer, Rory J. McCrimmon, Alexander S.F. Doney, Chim C. Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12669 |
Similar Items
-
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
by: Francesco Tona, et al.
Published: (2021-03-01) -
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
by: Domenico D’Amario, et al.
Published: (2019-11-01) -
Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
by: Heng Zeng, et al.
Published: (2019-02-01) -
Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
by: Ariane A. Sickinghe, et al.
Published: (2019-07-01) -
Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
by: Sandy Joung, et al.
Published: (2019-05-01)